Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
Statement From Maria C. Carrillo, PhD, Alzheimer’s Association Chief Science Officer
In the News | AARP.org
In the News | Neurology Live
C.A.R.E. Pharmacy Award winner announced | Alzheimer's Association
New insights into factors that may predict, increase or protect against the impact of COVID-19 on memory & thinking were revealed by studies reported at AAIC.
The Alzheimer’s Association celebrates Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association, for receiving the Lifetime Achievement Award
Maria C. Carrillo, Ph.D., Chief Science Officer at the Alzheimer’s Association, has been appointed to the International Brain Bee (IBB) Board of Directors.
Alzheimer's News, 6/24/2015 | Alzheimer's Association
Attributable to Maria C. Carrillo, Ph.D. Alzheimer’s Association chief science officer.
Chief Science Officer: Any Promising Science Should Be Pursued or Shared With Research Community
The Alzheimer’s Association is pleased with the announcement today that the FDA has revised the prescribing label for Aduhelm™ (aducanumab).
Alzheimer's News, 3/5/2015 | Alzheimer's Association
Alzheimer News 9/22/2008 | Alzheimer's Association
Neither gantenerumab or solanezumab met its primary outcome, which was a slowing of cognitive decline as measured by multiple tests of thinking and memory.
Funding will help expand the Dominantly Inherited Alzheimer’s Network Trials Unit to include anti-tau drugs
Leading voices in the Alzheimer’s and dementia scientific community underscored that Aduhelm™ (aducanumab) be made available to the population who may benefit.
The Alzheimer’s Association commits $10.85 million to a venture capital fund that invests in companies developing promising treatments for Alzheimer’s.
In the News | Alzheimer's Association
ECHO Model to Emphasize High-Quality, Person-Centered Care in Long-Term, Community-Based Care Settings
An expert work group has developed an improved definition of clinical meaningfulness in Alzheimer's.
Alzheimer News 11/3/2008 | Alzheimer's Association
SPRINT MIND 2.0 to Clarify Role of Intensive Blood Pressure Lowering in
Reducing Dementia Risk
Bill Gates Funds $10 Million Grant in Match Challenge to Fuel Research and Accelerate Alzheimer’s Treatment
Global research program provides strategic funding to fuel Alzheimer’s and dementia science and accelerate treatment
AAIC® Neuroscience Next to focus on discovery science from early-career researchers
The Alzheimer's Association, along with other clinical research experts, announced The National Treatment and Diagnostic Alzheimer's Registry.
The Alzheimer’s Association®, with the GHR Foundation and Edward Jones, announced a $14 million commitment
Training and exam are aimed at implementing latest evidenced-based practices to ensure quality dementia care for a growing number of Americans
CMS has created unnecessary barriers for individuals with Alzheimer’s disease.
Plus, Part the Cloud awards $4.75 million to six new, innovative clinical trials
The Alzheimer’s Association appreciates the generosity of the Erb Family Foundation and its ongoing commitment to advance Alzheimer’s and dementia research
Leaders of the U.S. POINTER Study announced a historic milestone: recruiting for the clinical trial has been successfully completed.
The Alzheimer’s Association is disappointed by the topline results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study of solanezumab.
Scientists, clinicians and health professionals will discuss the latest Alzheimer’s and dementia research in Latin America at the AAIC Satellite Symposium.
More than 200 attendees gathered to hear from leading Alzheimer’s experts about how Part the Cloud propels progress in dementia research.
The Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.
Alzheimer News 3/24/2009 | Alzheimer's Association
Alzheimer's News 3/20/2012 | Alzheimer's Association
Alzheimer's News 10/25/2012 | Alzheimer's Association
Alzheimer’s Association, SAGE Issue Brief Identifies Barriers to Care, Recommendations for Improving Care for LGBT Elders
Alzheimer’s Association, Rainwater Charitable Foundation Join Forces
Alzheimer’s Discriminates Against Women: Far More Women Than Men Impacted by Alzheimer’s, Numbers Growing Fast
Significant Part the Cloud Research Funding to Examine Adult Stem Cells and Neuroinflammation
The expanded study will be the first large-scale investigation of how lifestyle interventions affect Alzheimer’s and dementia in the brain.
Grants Support New Approaches to Treatment of Alzheimer’s and Other Dementias
The Alzheimer’s Association and University College London (UCL) are partnering to study brain aging and dementia
Alzheimer’s Association Part the Cloud Program Takes the Field a Step Closer to Effective Therapy With Five New Grants
To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects
Alzheimer’s Association and American College of Radiology (ACR) announce recruiting for the New IDEAS Study
The Alzheimer’s Association recognized six trailblazers in neuroscience research and mentorship at the second annual AAIC Neuroscience Next.
The Alzheimer’s Association and The Joint Commission today announced a collaboration to help improve quality and safety in dementia care in nursing.
Dementia researchers at all career stages will gather Dec. 6-9 in Nairobi, Kenya at Dementia and Brain Aging in Low- and Middle-Income Countries (LMICs)
Association Renews Urgent Call for CMS to Cover FDA-Approved Alzheimer’s Treatments
New PSAs from the Ad Council, Alzheimer’s Association and NASCAR encourage families to talk about seeing a doctor together at the first signs of dementia.
The Alzheimer's Association welcomes the positive data on the Phase 3 clinical trial of donanemab for treatment of early symptomatic Alzheimer's disease.
Brain Donation Helps Researchers Continue the Fight Against Alzheimer’s
The Alzheimer’s Association recognized six pioneers in neuroscience research and mentorship at the third AAIC® Neuroscience Next conference.
First Phase of Nationwide Study Demonstrates Clinical Impact of Amyloid PET Imaging
The 2023 Facts and Figures report examines patients' and doctors' reluctance to address memory concerns, which hinders diagnosis and access to new treatments.
Discover our progress and mission-related accomplishments within our six strategic objectives.
"ISTAART Grant Program for Conferences and Convenings (IGPCC)
ALZ-NET collects clinical and safety data and tracks long-term health outcomes for patients treated with new FDA-approved Alzheimer’s disease treatments.
Read the Alzheimer's Association report "Changing the Trajectory of Alzheimer's Disease: How a Treatment by 2025 Saves Lives and Dollars" – download now.
Latest clinical criteria for diagnosis of Alzheimer's disease issued by the Alzheimer's Association and the NIH – with updated guidelines on biomarker data.
The Michigan Chapter has been named a 2020 grant recipient by the Community Foundation for Southeast Michigan through the Ralph C. Wilson, Jr. Legacy Funds.
The Alzheimer's Association Houston & Southeast Texas Chapter is a tax-exempt, 501(c)(3) nonprofit, donor-supported organization.
The Alzheimer's Association is a 501(c)(3) nonprofit organization. Contributions are 100% tax deductible to the extent provided by law.
The Desert Southwest Chapter is a tax-exempt, 501(c)(3) nonprofit, donor-supported organization.
The Greater Kentucky/Southern Indiana Chapter is a tax-exempt, 501(c)(3) nonprofit, donor-supported organization.
The Nebraska Chapter is a tax-exempt, 501(c)(3) nonprofit, donor-supported organization.
Marshall Health and the Marshall University Joan C. Edwards School of Medicine will launch a new experience
Alzheimer's Association, Georgia Chapter has been serving the Georgia area since 1982 and has seven regional offices.
Your donation can make a difference in the lives of individuals with Alzheimer's and their caregivers and families.
Donate to the Alzheimer's Association.
The Alzheimer's Association is a 501(c)3 committed to helping those living with Alzheimer's and other dementia, and their families in Central & North Florida.
The Alzheimer's Association is a 501(c)3 committed to helping those living with Alzheimer's and related dementia and their families in Southeast Florida Chapter
Support groups provide a place for friends and family to share valuable information, caregiving tips and concerns throughout their Alzheimer's journey.
By Sarah Taddeo, Democrat and Chronicle, March 6, 2020
Thank you to the following organizations for their dedication to our Chapter's mission.
The Heart of America Chapter serves 66 counties in Kansas and Missouri. We offer education and support services to those with Alzheimer's and their caregivers.
The Illinois Chapter values all of the donors who make its work possible.
Respite provides relief to people caring for those with Alzheimer’s disease or a related dementia, helps reduce stress and improve the quality of care provided.
Scott J. Heald
Medical Properties Trust, Inc.
Learn more about the Western New York Chapter of the Alzheimer's Association.
Make a general donation or a memorial/tribute gift to honor a friend or family member.
Whether you need information about diagnosis, caregiving or support groups we are here for you.
Meet some of the staff and volunteers who advance our mission.
Saturday's session of Navigating the Journey Through Dementia Care, is a learning opportunity offered at no cost to family caregivers.
Learn about the Desert Southwest Chapter.
Every dollar donated benefits those affected by Alzheimer's disease in your community.
We provide supportive services and resources in communities throughout 29 counties in Utah.
The Illinois Chapter is a tax-exempt, 501(c) 3 nonprofit, donor-supported organization.
Since 1980, the Alzheimer's Association of Colorado has led the fight against Alzheimer's disease.
The Alzheimer's Association, New Mexico Chapter. 1 (800) 272-3900.
The Alzheimer's Association is a 501(c)3 committed to helping those living with Alzheimer's and related dementia, and their families in Florida Gulf Coast.
The Council is intended to improve and enhance quality of life and support, and services for individuals living with Alzheimer's disease and related disorders.
The Alzheimer’s Association serves families locally with dedicated staff members who provide education, support services, volunteerism, advocacy efforts & more.
Take the Brain Tour